About Us

BioLamina develops and distributes high quality products for cell culture based on genetically engineered proteins, called laminins. This technology is based on research from Dr. Karl Tryggvason’s laboratory at the Karolinska Institutet, Sweden and Duke-NUS, Singapore. By covering surfaces used for cell culture with recombinant laminins, the cell's natural environment in the body is mimicked, allowing the cells to thrive and maintain their function. These substrates help to solve several issues associated with embryonic stem cell culture as well as other primary cells, such as low cell growth and quality. With the introduction of BioLamina’s more biologically relevant and defined matrices, scientists now have more powerful resources to develop their cultivation systems, enabling clinical development and the production of new cell therapies. For more information: www.biolamina.com